Liquid-liquid polymer leuprolide acetate (LA) formulations comprising a biodegradable polymer and biocompatible solvent, and methods of using the formulations.
A61K 47/34 - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
05 - Pharmaceutical, veterinary and sanitary products
Goods & Services
(1) Pharmaceutical preparations for the treatment of hormonal related diseases and disorders namely hypogonadism, testosterone, androgen and estrogen disorders
05 - Pharmaceutical, veterinary and sanitary products
Goods & Services
(1) Pharmaceutical preparations for the treatment of hormonal related diseases and disorders namely hypogonadism, testosterone, androgen and estrogen disorders
7.
SYSTEMS AND METHODS FOR MIXING SYRINGE VALVE ASSEMBLIES
A syringe mixing system is provided for housing and mixing contents between at least two syringes. In some embodiments, a syringe coupler is provided that receives first and second syringes and includes a valve member that is convertible between a closed position and an open position. Retention systems for preventing or inhibiting removal of at least one syringe after use are also provided.
Liquid polymer pharmaceutical compositions with a biodegradable liquid polyester that has a carboxylic acid end group, a biocompatible solvent, and an active pharmaceutical agent are useful for administration into the body to provide extended long term release of the drug.
A61K 31/568 - Compounds containing cyclopenta[a]hydrophenanthrene ring systemsDerivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstane, testosterone
A61K 9/00 - Medicinal preparations characterised by special physical form
A61K 38/29 - Parathyroid hormone, i.e. parathormoneParathyroid hormone-related peptides
A61K 47/34 - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
A61K 47/59 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
Disclosed herein are biodegradable poly(lactide-co-glycolide) (PLG) polymer compositions that are administered into the body with syringes or needles and that are utilized to deliver a testosterone into the body over an extended period of time.
A61K 31/568 - Compounds containing cyclopenta[a]hydrophenanthrene ring systemsDerivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstane, testosterone
A61K 47/34 - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
A61K 9/00 - Medicinal preparations characterised by special physical form
A61P 5/24 - Drugs for disorders of the endocrine system of the sex hormones
13.
Systems and methods for mixing syringe valve assemblies
A syringe mixing system is provided for housing and mixing contents between at least two syringes. In some embodiments, a syringe coupler is provided that receives first and second syringes and includes a valve member that is convertible between a closed position and an open position. Retention systems for preventing or inhibiting removal of at least one syringe after use are also provided.
Pharmaceutical compositions comprising a biodegradable polymer, a solvent system, and an active pharmaceutical ingredient suitable for extended storage and delivery of the active pharmaceutical ingredient contained therein are disclosed, along with methods of making and using the same.
A61K 9/00 - Medicinal preparations characterised by special physical form
A61K 47/34 - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
15.
LIQUID POLYMER COMPOSITIONS AND SYSTEMS FOR EXTENDED DELIVERY OF PEPTIDES AS ACTIVE PHARMACEUTICAL INGREDIENTS
Liquid polymer pharmaceutical compositions with a biodegradable liquid polymer, a biocompatible solvent or combination or mixture of solvents and/or co-solvents, and an active pharmaceutical agent comprising a peptide are useful to provide extended long-term release of the drug to a subject and/or to improve the stability of the active pharmaceutical agent. In embodiments, the polymer may be initiated with a low-molecular weight polyethylene glycol and/or may be a block copolymer comprising a low-molecular weight polyethylene glycol block. In further embodiments, the liquid polymer pharmaceutical composition may include a divalent cation, which may be provided in the form of a metal salt.
A61K 47/34 - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
A syringe mixing system is provided for housing and mixing contents between at least two syringes. In some embodiments, a syringe coupler is provided that receives first and second syringes and includes a valve member that is convertible between a closed position and an open position. Retention systems for preventing or inhibiting removal of at least one syringe after use are also provided.
An extended release formulation is provided for use in a method for the treatment of Central Precocious Puberty (CPP) in pediatric patients 2 years of age or older. The extended release formulation comprises leuprolide or a pharmaceutically acceptable salt thereof, a biodegradable polymer, and a biocompatible organic solvent. The biodegradable polymer is comprised of poly(lactide-co-glycolide) (PLG) copolymer segments, poly(lactic acid-co-glycolic acid) (PLGA) copolymer segments, poly(lactide) (PL) polymer segments, poly(lactic acid) (PLA) polymer segments, or a combination thereof. The extended release formulation is administered as a subcutaneous injection of a flowable composition that forms a solid in situ depot. The extended release formulation releases leuprolide for a period of about 6 months for the effective treatment of CPP within a pediatric patient.
A61K 47/34 - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
A61K 47/34 - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
A61K 9/00 - Medicinal preparations characterised by special physical form
A61K 31/138 - Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
A61K 31/566 - Compounds containing cyclopenta[a]hydrophenanthrene ring systemsDerivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol having an oxo group in position 17, e.g. oestrone
A61K 47/22 - Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
A syringe mixing system is provided for housing and mixing contents between at least two syringes. In some embodiments, a syringe coupler is provided that receives first and second syringes and includes a valve member that is convertible between a closed position and an open position. Retention systems for preventing or inhibiting removal of at least one syringe after use are also provided.
A syringe mixing system is provided for housing and mixing contents between at least two syringes. In some embodiments, a syringe coupler is provided that receives first and second syringes and includes a valve member that is convertible between a closed position and an open position. Retention systems for preventing or inhibiting removal of at least one syringe after use are also provided.
Disclosed herein are biodegradable poly(lactide-co-glycolide) (PLG) polymer compositions that are administered into the body with syringes or needles and that are utilized to deliver a testosterone into the body over an extended period of time.
A61K 9/00 - Medicinal preparations characterised by special physical form
A61K 31/568 - Compounds containing cyclopenta[a]hydrophenanthrene ring systemsDerivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstane, testosterone
A61K 47/22 - Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
A61K 47/34 - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
25.
BIODEGRADABLE POLYMER DELIVERY SYSTEM FOR EXTENDED DELIVERY OF TESTOSTERONE
Disclosed herein are biodegradable poly(lactide-co-glycolide) (PLG) polymer compositions that are administered into the body with syringes or needles and that are utilized to deliver a testosterone into the body over an extended period of time.
A61K 9/00 - Medicinal preparations characterised by special physical form
A61K 31/568 - Compounds containing cyclopenta[a]hydrophenanthrene ring systemsDerivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstane, testosterone
A61K 47/22 - Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
A61K 47/34 - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
26.
BIODEGRADABLE POLYMER AND SOLVENT COMPOSITIONS AND SYSTEMS FOR EXTENDED STORAGE AND DELIVERY OF ACTIVE PHARMACEUTICAL INGREDIENTS
Pharmaceutical compositions comprising a biodegradable polymer, a solvent system, and an active pharmaceutical ingredient suitable for extended storage and delivery of the active pharmaceutical ingredient contained therein are disclosed, along with methods of making and using the same.
A61K 47/14 - Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
A61K 47/20 - Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
A61K 47/22 - Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
A61K 47/34 - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
A61K 31/568 - Compounds containing cyclopenta[a]hydrophenanthrene ring systemsDerivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstane, testosterone
Pharmaceutical compositions comprising a biodegradable polymer, a solvent system, and an active pharmaceutical ingredient suitable for extended storage and delivery of the active pharmaceutical ingredient contained therein are disclosed, along with methods of making and using the same.
A61K 31/568 - Compounds containing cyclopenta[a]hydrophenanthrene ring systemsDerivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstane, testosterone
A61K 47/14 - Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
A61K 47/20 - Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
A61K 47/22 - Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
A61K 47/34 - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
28.
LIQUID POLYMER DELIVERY SYSTEM FOR EXTENDED ADMINISTRATION OF DRUGS
Liquid polymer pharmaceutical compositions comprising a biodegradable liquid polymer, a biocompatible solvent system, and an active pharmaceutical ingredient (API) are disclosed. The compositions of the invention are useful for providing extended, long-term release of the API.
A61K 31/568 - Compounds containing cyclopenta[a]hydrophenanthrene ring systemsDerivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstane, testosterone
A61K 9/00 - Medicinal preparations characterised by special physical form
A61K 47/34 - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
A61K 47/22 - Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
Liquid polymer pharmaceutical compositions with a biodegradable liquid polymer, a biocompatible solvent or combination or mixture of solvents and/or co-solvents, and an active pharmaceutical agent comprising a peptide are useful to provide extended long-term release of the drug to a subject and/or to improve the stability of the active pharmaceutical agent. In embodiments, the polymer may be initiated with a low-molecular weight polyethylene glycol and/or may be a block copolymer comprising a low-molecular weight polyethylene glycol block. In further embodiments, the liquid polymer pharmaceutical composition may include a divalent cation, which may be provided in the form of a metal salt.
A61K 9/00 - Medicinal preparations characterised by special physical form
A61K 47/34 - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
Liquid polymer pharmaceutical compositions with a biodegradable liquid polymer, a biocompatible solvent or combination or mixture of solvents and/or co-solvents, and an active pharmaceutical agent comprising a peptide are useful to provide extended long-term release of the drug to a subject and/or to improve the stability of the active pharmaceutical agent. In embodiments, the polymer may be initiated with a low-molecular weight polyethylene glycol and/or may be a block copolymer comprising a low-molecular weight polyethylene glycol block. In further embodiments, the liquid polymer pharmaceutical composition may include a divalent cation, which may be provided in the form of a metal salt.
A61K 47/34 - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
34.
Liquid polymer delivery system for extended administration of drugs
Liquid polymer pharmaceutical compositions with a biodegradable liquid polyester that has a carboxylic acid end group, a biocompatible solvent, and an active pharmaceutical agent are useful for administration into the body to provide extended long term release of the drug.
A61K 31/568 - Compounds containing cyclopenta[a]hydrophenanthrene ring systemsDerivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstane, testosterone
A61K 9/00 - Medicinal preparations characterised by special physical form
A61K 47/34 - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
A61K 47/59 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
A61K 9/00 - Medicinal preparations characterised by special physical form
A61K 47/34 - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
in situin situ depot. The extended release formulation releases leuprolide for a period of about 6 months for the effective treatment of CPP within a pediatric patient.
A61K 47/34 - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
A61P 5/02 - Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
36 - Financial, insurance and real estate services
Goods & Services
Consulting and information concerning insurance; insurance services, namely, insurance eligibility review and verification and consultation in the health industry; and providing information in insurance matters
36 - Financial, insurance and real estate services
Goods & Services
Consulting and information concerning insurance; insurance services, namely, insurance eligibility review and verification and consultation in the health industry; and providing information in insurance matters
36 - Financial, insurance and real estate services
Goods & Services
Consulting and information concerning insurance; insurance services, namely, insurance eligibility review and verification and consultation in the health industry; and providing information in insurance matters
41.
LIQUID POLYMER DELIVERY SYSTEM FOR EXTENDED ADMINISTRATION OF DRUGS
Liquid polymer pharmaceutical compositions comprising a biodegradable liquid polymer, a biocompatible solvent system, and an active pharmaceutical ingredient (API) are disclosed. The compositions of the invention are useful for providing extended, long-term release of the API.
A61K 9/00 - Medicinal preparations characterised by special physical form
A61K 31/568 - Compounds containing cyclopenta[a]hydrophenanthrene ring systemsDerivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstane, testosterone
A61P 15/10 - Drugs for genital or sexual disordersContraceptives for impotence
42.
LIQUID POLYMER DELIVERY SYSTEM FOR EXTENDED ADMINISTRATION OF DRUGS
Liquid polymer pharmaceutical compositions comprising a biodegradable liquid polymer, a biocompatible solvent system, and an active pharmaceutical ingredient (API) are disclosed. The compositions of the invention are useful for providing extended, long-term release of the API.
A61K 9/00 - Medicinal preparations characterised by special physical form
A61K 31/568 - Compounds containing cyclopenta[a]hydrophenanthrene ring systemsDerivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstane, testosterone
A61P 15/10 - Drugs for genital or sexual disordersContraceptives for impotence
Liquid polymer pharmaceutical compositions with a biodegradable liquid polyester that has a carboxylic acid end group, a biocompatible solvent, and an active pharmaceutical agent are useful for administration into the body to provide extended long term release of the drug.
A61K 9/00 - Medicinal preparations characterised by special physical form
A61K 47/00 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient
A61K 31/00 - Medicinal preparations containing organic active ingredients
A61K 31/568 - Compounds containing cyclopenta[a]hydrophenanthrene ring systemsDerivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstane, testosterone
A61K 47/34 - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
A61K 47/59 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
42 - Scientific, technological and industrial services, research and design
44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services
Goods & Services
Scientific and technological services, namely, scientific research data analysis in the field of medicine and pharmaceuticals; scientific and technological services, namely, design and development of computer hardware and software for pharmacy inventory control and patient management of pharmaceuticals; laboratory research services relating to pharmaceuticals; industrial research in the field of topical and specialty injectable pharmaceuticals; scientific research; medical, pharmaceutical, chemical and biological research; scientific research in the field of drug discovery and development for others; biomedical research services; research and testing services in the fields of bacteriology and virology; quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the field of oncology, topical and specialty injectable pharmaceuticals Medical services; health care; health care services in the nature of pharmaceutical consulting service and pharmaceutical and medicinal advisory services in the field of products and substances for human use; medical assistance consultancy provide by doctors and other specialized medical personnel
42 - Scientific, technological and industrial services, research and design
44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services
Goods & Services
Scientific and technological services, namely, scientific research data analysis in the field of medicine and pharmaceuticals; scientific and technological services, namely, design and development of computer hardware and software for pharmacy inventory control and patient management of pharmaceuticals; laboratory research services relating to pharmaceuticals; industrial research in the field of topical and specialty injectable pharmaceuticals; scientific research; medical, pharmaceutical, chemical and biological research; scientific research in the field of drug discovery and development for others; biomedical research services; research and testing services in the fields of bacteriology and virology; quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the field of oncology, topical and specialty injectable pharmaceuticals Medical services; health care; health care services in the nature of pharmaceutical consulting service and pharmaceutical and medicinal advisory services in the field of products and substances for human use; medical assistance consultancy provide by doctors and other specialized medical personnel
05 - Pharmaceutical, veterinary and sanitary products
10 - Medical apparatus and instruments
Goods & Services
Pharmaceutical and medical preparations for the treatment of arthritis, autoimmune diseases, the immune system, the respiratory system, musculoskeletal system, genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, oncology, in gynecology and urology, for use in gastroenterology, and antibacterials, anti-virals, antibiotics and anti-fungals for the treatment of viral and bacterial infections; pharmaceutical preparations for the treatment of central precocious puberty; pharmaceutical delivery systems comprising implantable subcutaneous drug delivery devices sold filled with pharmaceutical preparations for the palliative treatment of advanced prostate cancer; drug delivery agents in the form of powders that provide controlled release of the active ingredients for a variety of pharmaceuticals; pharmaceutical preparations for the treatment of cancer; drug delivery systems, namely, drug delivery agents consisting of compounds that facilitate delivery of pharmaceuticals for the treatment of cancer; pharmaceutical delivery systems comprising an active pharmaceutical ingredient in a biodegradable polymer for the continuous release of a wide variety of therapeutic agents Medical devices, namely, implantable subcutaneous drug delivery devices sold empty; implantable subcutaneous drug delivery devices sold empty but used in the treatment of cancer; medical apparatus, namely, injection devices for pharmaceuticals
05 - Pharmaceutical, veterinary and sanitary products
10 - Medical apparatus and instruments
Goods & Services
Pharmaceutical and medical preparations for the treatment of arthritis, autoimmune diseases, the immune system, the respiratory system, musculoskeletal system, genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, oncology, in gynecology and urology, for use in gastroenterology, and antibacterials, anti-virals, antibiotics and anti-fungals for the treatment of viral and bacterial infections; pharmaceutical preparations for the treatment of central precocious puberty; pharmaceutical delivery systems comprising implantable subcutaneous drug delivery devices sold filled with pharmaceutical preparations for the palliative treatment of advanced prostate cancer; drug delivery agents in the form of powders that provide controlled release of the active ingredients for a variety of pharmaceuticals; pharmaceutical preparations for the treatment of cancer; drug delivery systems, namely, drug delivery agents consisting of compounds that facilitate delivery of pharmaceuticals for the treatment of cancer; pharmaceutical delivery systems comprising an active pharmaceutical ingredient in a biodegradable polymer for the continuous release of a wide variety of therapeutic agents Medical devices, namely, implantable subcutaneous drug delivery devices sold empty; implantable subcutaneous drug delivery devices sold empty but used in the treatment of cancer; medical apparatus, namely, injection devices for pharmaceuticals
05 - Pharmaceutical, veterinary and sanitary products
10 - Medical apparatus and instruments
42 - Scientific, technological and industrial services, research and design
44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services
Goods & Services
Pharmaceutical and/or medical preparations and substances; pharmaceutical preparations for the treatment of central precocious puberty; pharmaceutical delivery systems; implantable liquid or flowable compositions; sustained release materials for release of medicaments; pharmaceutical preparations for the treatment of cancer; drug delivery systems, namely, drug delivery formulations and drug delivery agents for the treatment of cancer. Medical devices; drug delivery systems; drug delivery systems, namely, drug delivery apparatus and drug delivery devices; drug delivery systems, namely, drug delivery apparatus and drug delivery devices for the treatment of cancer; medical apparatus, guided tissue regeneration barrier products, devices for use in periodontal or other tissue regeneration treatment, and guided tissue regeneration barrier products or devices in kit form. Scientific and technological services and research and design relating thereto; pharmaceutical laboratory services; industrial analysis and research services; scientific analysis; medical, pharmaceutical, chemical and biological research; scientific research in the field of genetics and genetic engineering; research and scientific analysis relating to drug discovery and development for others; pharmaceutical research and development; research, development and consultancy in the field of biomedicine and cell culture engineering; research and testing services in the fields of bacteriology and virology; rental of laboratory apparatus and instruments; quality-control services. Medical services; health services; pharmacy services; pharmacy advice; pharmacy advisory services; medical diagnostics and analysis consultancy; medical assistance consultancy provided by doctors and other specialised medical personnel; veterinary services; hygienic and beauty care for human beings and animals; agriculture, horticulture and forestry services.
05 - Pharmaceutical, veterinary and sanitary products
10 - Medical apparatus and instruments
42 - Scientific, technological and industrial services, research and design
44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services
Goods & Services
Pharmaceutical and/or medical preparations and substances; pharmaceutical preparations for the treatment of central precocious puberty; pharmaceutical delivery systems; implantable liquid or flowable compositions; sustained release materials for release of medicaments; pharmaceutical preparations for the treatment of cancer; drug delivery systems, namely, drug delivery formulations and drug delivery agents for the treatment of cancer; none of the aforesaid goods being health food supplements or vitamins and none of the aforesaid goods having a base of zeolite and silicic acid. Medical devices; drug delivery systems; drug delivery systems, namely, drug delivery apparatus and drug delivery devices; drug delivery systems, namely, drug delivery apparatus and drug delivery devices for the treatment of cancer; medical apparatus, guided tissue regeneration barrier products, devices for use in periodontal or other tissue regeneration treatment, and guided tissue regeneration barrier products or devices in kit form. Scientific and technological services and research and design relating thereto; pharmaceutical laboratory services; industrial analysis and research services; scientific analysis; medical, pharmaceutical, chemical and biological research; scientific research in the field of genetics and genetic engineering; research and scientific analysis relating to drug discovery and development for others; pharmaceutical research and development; research, development and consultancy in the field of biomedicine and cell culture engineering; research and testing services in the fields of bacteriology and virology; rental of laboratory apparatus and instruments; quality-control services. Medical services; health services; pharmacy services; pharmacy advice; pharmacy advisory services; medical diagnostics and analysis consultancy; medical assistance consultancy provided by doctors and other specialised medical personnel; veterinary services; hygienic and beauty care for human beings and animals; agriculture, horticulture and forestry services.
05 - Pharmaceutical, veterinary and sanitary products
42 - Scientific, technological and industrial services, research and design
44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services
Goods & Services
Pharmaceutical and/or medical preparations and substances for human use; Veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. Scientific and technological services and research and design relating thereto; pharmaceutical laboratory services; industrial analysis and research services; scientific analysis; medical, pharmaceutical, chemical, biological and cosmetological research; scientific research in the field of genetics and genetic engineering; research and scientific analysis relating to drug discovery and development for others; pharmaceutical research and development; research, development and consultancy in the field of biomedicine and cell culture engineering; research and testing services in the fields of bacteriology and virology; rental of laboratory apparatus and instruments; quality-control services. Services rendered by pharmacy professionals; medical diagnostics and analysis consultancy; Services of doctors; veterinary services; hygienic and beauty care for human beings and animals; agriculture, horticulture and forestry services.
65.
LIQUID POLYMER DELIVERY SYSTEM FOR EXTENDED ADMINISTRATION OF DRUGS
Liquid polymer pharmaceutical compositions with a biodegradable liquid polyester that has a carboxylic acid end group, a biocompatible solvent, and an active pharmaceutical agent are useful for administration into the body to provide extended long term release of the drug.
A61K 47/34 - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
A61K 31/568 - Compounds containing cyclopenta[a]hydrophenanthrene ring systemsDerivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstane, testosterone
42 - Scientific, technological and industrial services, research and design
Goods & Services
Management services provided to pharmacies for controlling drug inventories Providing temporary use of non-downloadable software for pharmacy inventory control
36 - Financial, insurance and real estate services
Goods & Services
Consulting and information concerning insurance; Insurance services, namely, insurance eligibility review and verification and consultation in the health industry; and providing information in insurance matters
05 - Pharmaceutical, veterinary and sanitary products
Goods & Services
(1) Pharmaceutical preparations for medical purposes for the prevention and treatment of musculoskeletal system diseases, namely, pharmaceutical products, namely, anti-inflammatory, and pharmaceutical preparations for the treatment of arthritis; Pharmaceutical preparations for medical purposes for the prevention and treatment of genitourinary system diseases, namely, anti-fungal, and pharmaceutical preparations for bacterial vaginosis; Pharmaceutical preparations for medical purposes for use in dermatology affections, namely, acne, rosacea, onychomicosis; Pharmaceutical preparations for medical purposes for the prevention and treatment of oncologic diseases, namely, prostatic cancer, nutritional disorders, namely, mineral deficiency and toxicity, obesity, metabolic syndrome, under nutrition, vitamin deficiency, dependency and toxicity, autoimmune diseases, ocular disorders and diseases, and pharmaceutical preparations for the prevention and treatment of disorders and diseases of the cardiovascular system, respiratory system, and pharmaceutical preparations for use in opthalmology and urology; Pharmaceutical preparations for medical purposes for use in the gastroenterological area; and Pharmaceutical preparations, namely, anti-bacterial, anti-viral, antibiotics and anti-fungal for the treatment of viral and bacterial infections.
05 - Pharmaceutical, veterinary and sanitary products
Goods & Services
Pharmaceutical preparations for medical purposes for the prevention and/or treatment of arthritis, nutritional disorders, autoimmune diseases, ocular disorders and diseases, inflammatory disorders, immune system, cardiovascular system, respiratory system, muscoloskeletal system, genitourinary system, and for use in dermatology, oncology, opthalmology, gyneacology and urology, and for use in the gastroenterological area and pharmaceutical preparations, namely, anti-bacterial, anti-virals, antibiotics and anti-fungals fo the treatment of viral and bacterial infections; excluding antiallergenic.
05 - Pharmaceutical, veterinary and sanitary products
35 - Advertising and business services
39 - Transport, packaging, storage and travel services
42 - Scientific, technological and industrial services, research and design
Goods & Services
(1) Pharmaceutical preparations and substances, namely, oncologicals, ginecologicals, urologicals, cardiovasculars, antihistamines, anti-arthritics, anti-infectives, anti-fungals, anti-depressants, namely, anthelmintics, antibiotics, vitamins, minerals, anticoccidials, feed additives, hematinics, antimicrobials, caloric replacement solutions, psycotherapeutics, anti-inflamatories, preparations for sexual dysfunction, anti-hypertensives, anti-diabetics; toiletry and health care preparations, namely, topical corticosteroids, ophthalmic solutions, anti-pruritics, analgesics, sleep aids, dental plaque remover, eye drops for artificial tears, nutritional and dietary supplements, namely vitamins, minerals, oligoelements, aminoacids, proteins, glucosamine and chondroitrine. (1) Operation of a business selling pharmaceutical products and dietary supplements, namely arranging for the distribution of pharmaceutical products and dietary supplements which contain vitamins, minerals, oligoelements, aminoacids, proteins, glucosamine and chondroitrine to retailers and/or wholesalers.
(2) Transport, distribution and storage services of drugs and other pharmaceutical and/or medicinal products.
(3) Scientific research and analysis services for further application in the medical and/or pharmaceutical fields.
05 - Pharmaceutical, veterinary and sanitary products
42 - Scientific, technological and industrial services, research and design
44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services
Goods & Services
Pharmaceutical and/or medical preparations and substances for human use; Veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. Scientific and technological services and research and design relating thereto; pharmaceutical laboratory services; industrial analysis and research services; scientific analysis; medical, pharmaceutical, chemical, biological and cosmetological research; scientific research in the field of genetics and genetic engineering; research and scientific analysis relating to drug discovery and development for others; pharmaceutical research and development; research, development and consultancy in the field of biomedicine and cell culture engineering; research and testing services in the fields of bacteriology and virology; rental of laboratory apparatus and instruments; quality-control services. Services rendered by pharmacy professionals; medical diagnostics and analysis consultancy; Services of doctors; veterinary services; hygienic and beauty care for human beings and animals; agriculture, horticulture and forestry services.
05 - Pharmaceutical, veterinary and sanitary products
39 - Transport, packaging, storage and travel services
42 - Scientific, technological and industrial services, research and design
44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services
Goods & Services
pharmaceutical and medicinal products and substances humans use, namely, pharmaceutical and medicinal preparations for the prevention and or treatment of arthritis, [ nutritional disorders, ] autoimmune diseases, disorders in the nervous system, the immune system, [ the cardiovascular system, the respiratory system, ] musculoskeletal system, genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, [ in ophthalmology, ] in gynecology and urology; for use in the gastroenterological area; [ for the prevention and treatment of ocular disorders and diseases, ] and antibacterials, anti-virals, antibiotics and anti-fungals for the treatment of viral and bacterial infections transport by truck [, train, ferry, boat, railroad or air, ] and storage of drugs, pharmaceuticals and medicinal products scientific research and service of analyses for varied applications in the medical and pharmaceutical field pharmaceutical consulting service and pharmaceutical and medicinal advisory services in the field of products and substances for human use
05 - Pharmaceutical, veterinary and sanitary products
10 - Medical apparatus and instruments
Goods & Services
Pharmaceutical delivery systems; implantable liquid or flowable compositions; sustained release materials for release of medicaments. Medical apparatus, guided tissue regeneration barrier products, devices for use in periodontal or other tissue regeneration treatment, and guided tissue regeneration barrier products or devices in kit form.
